Bio-Rad Laboratories ROE 2006-2018 | BIO

Current and historical return on equity (ROE) values for Bio-Rad Laboratories (BIO) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Bio-Rad Laboratories ROE for the three months ending September 30, 2018 was 3.72%.
Bio-Rad Laboratories ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2018-09-30 $1.28B $4.90B 30.12%
2018-06-30 $1.03B $4.64B 27.64%
2018-03-31 $0.77B $4.49B 23.46%
2017-12-31 $0.12B $2.93B 4.32%
2017-09-30 $0.02B $2.85B 0.58%
2017-06-30 $0.01B $2.81B 0.44%
2017-03-31 $0.03B $2.71B 0.94%
2016-12-31 $0.03B $2.58B 0.96%
2016-09-30 $0.09B $2.70B 3.63%
2016-06-30 $0.09B $2.62B 3.69%
2016-03-31 $0.10B $2.54B 4.19%
2015-12-31 $0.11B $2.49B 4.60%
2015-09-30 $0.10B $2.43B 4.45%
2015-06-30 $0.10B $2.36B 4.35%
2015-03-31 $0.10B $2.20B 4.59%
2014-12-31 $0.09B $2.19B 4.07%
2014-09-30 $0.08B $2.18B 3.66%
2014-06-30 $0.06B $2.25B 2.82%
2014-03-31 $0.07B $2.23B 3.02%
2013-12-31 $0.08B $2.19B 3.71%
2013-09-30 $0.09B $2.12B 4.42%
2013-06-30 $0.14B $2.07B 7.00%
2013-03-31 $0.15B $2.03B 7.86%
2012-12-31 $0.17B $2.02B 8.64%
2012-09-30 $0.18B $1.94B 9.88%
2012-06-30 $0.19B $1.85B 10.38%
2012-03-31 $0.18B $1.84B 10.11%
2011-12-31 $0.18B $1.74B 10.57%
2011-09-30 $0.19B $1.69B 11.38%
2011-06-30 $0.19B $1.73B 11.79%
2011-03-31 $0.18B $1.61B 12.51%
2010-12-31 $0.19B $1.54B 13.35%
2010-09-30 $0.16B $1.43B 11.75%
2010-06-30 $0.15B $1.30B 11.74%
2010-03-31 $0.15B $1.30B 12.16%
2009-12-31 $0.15B $1.28B 12.36%
2009-09-30 $0.10B $1.23B 8.83%
2009-06-30 $0.09B $1.13B 8.17%
2009-03-31 $0.09B $1.06B 8.66%
2008-12-31 $0.09B $1.07B 8.24%
2008-09-30 $0.11B $1.05B 10.33%
2008-06-30 $0.11B $1.12B 10.60%
2008-03-31 $0.09B $1.08B 9.44%
2007-12-31 $0.09B $0.97B 10.12%
2007-09-30 $0.10B $0.95B 11.12%
2007-06-30 $0.09B $0.90B 11.06%
2007-03-31 $0.10B $0.86B 12.29%
2006-12-31 $0.10B $0.82B 13.45%
2006-09-30 $0.10B $0.79B 13.65%
2006-06-30 $0.09B $0.76B 13.30%
2006-03-31 $0.08B $0.70B 11.82%
2005-12-31 $0.08B $0.66B 12.50%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $8.274B $2.160B
Bio-Rad Laboratories, Inc., together with its subsidiaries, engages in the manufacture and supply of products and systems for the life science research, healthcare, analytical chemistry, and other markets worldwide. The company's products are used to separate complex chemical and biological materials, and to identify, analyze, and purify their components. It operates in two segments, Life Science and Clinical Diagnostics. The Life Science segment offers electrophoresis, image analysis, molecular detection, chromatography, gene transfer, sample preparation, and amplification products and services. The Clinical Diagnostics segment provides control, autoimmune, diabetes, and blood virus testing products. Bio-Rad is renowned worldwide among hospitals, universities, major research institutions, as well as biotechnology and pharmaceutical companies for its commitment to quality and customer service. The company is headquartered in Hercules, California.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $126.543B 19.40
Abbott Laboratories (ABT) United States $126.526B 25.64
Stryker (SYK) United States $64.420B 24.28
Boston Scientific (BSX) United States $51.491B 26.02
Baxter (BAX) United States $35.393B 22.86
Zimmer Biomet Holdings (ZBH) United States $23.875B 15.48
Smith & Nephew SNATS (SNN) United Kingdom $16.038B 0.00
ResMed (RMD) United States $14.846B 28.31
Perrigo (PRGO) Ireland $8.596B 13.05
Canopy Growth (CGC) Canada $8.174B 0.00
Hill-Rom Holdings (HRC) United States $6.270B 19.88
Aurora Cannabis (ACB) Canada $6.172B 33.68
Haemonetics (HAE) United States $5.727B 50.36
ICU Medical (ICUI) United States $4.968B 27.68
Insulet (PODD) United States $4.838B 0.00
Agios Pharmaceuticals (AGIO) United States $4.052B 0.00
Hutchison China MediTech (HCM) China $4.010B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.990B 0.00
Neogen (NEOG) United States $3.294B 49.88
NuVasive (NUVA) United States $3.166B 29.46
National Vision Holdings (EYE) United States $3.024B 58.49
Quidel (QDEL) United States $2.507B 32.68
Aphria (APHA) $2.433B 0.00
NxStage Medical (NXTM) United States $1.933B 0.00
Phibro Animal Health (PAHC) United States $1.409B 19.95
AtriCure (ATRC) United States $1.241B 0.00
Cardiovascular Systems (CSII) United States $1.058B 1524.50
VAREX IMAGING (VREX) United States $0.999B 20.07
Meridian Bioscience (VIVO) United States $0.823B 26.23
Surmodics (SRDX) United States $0.794B 121.41
OraSure Technologies (OSUR) United States $0.772B 43.48
Eagle Pharmaceuticals (EGRX) United States $0.756B 24.24
MacroGenics (MGNX) United States $0.740B 0.00
Cerus (CERS) United States $0.716B 0.00
PetIQ (PETQ) United States $0.705B 20.03
Lantheus Holdings (LNTH) United States $0.625B 19.34
Omeros (OMER) United States $0.619B 0.00
LeMaitre Vascular (LMAT) United States $0.540B 26.52
Owens & Minor (OMI) United States $0.535B 6.05
Insys Therapeutics (INSY) United States $0.527B 0.00
NanoString Technologies (NSTG) United States $0.521B 0.00
TG Therapeutics (TGTX) United States $0.444B 0.00
Evolus (EOLS) United States $0.403B 0.00
Quanterix (QTRX) United States $0.376B 0.00
Utah Medical Products (UTMD) United States $0.332B 21.45
Cytosorbents (CTSO) United States $0.313B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.264B 0.00
Surface Oncology (SURF) United States $0.225B 0.00
Rockwell Medical (RMTI) United States $0.214B 0.00
BioLife Solutions (BLFS) United States $0.204B 275.00
Chimerix (CMRX) United States $0.172B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.146B 0.00
Fonar (FONR) United States $0.141B 7.06
Imprimis Pharmaceuticals (IMMY) United States $0.123B 0.00
Chembio Diagnostics (CEMI) United States $0.106B 0.00
United-Guardian (UG) United States $0.080B 16.85
Female Health (VERU) United States $0.075B 0.00
Oramed Pharmaceuticals (ORMP) Israel $0.070B 0.00
Trinity Biotech (TRIB) Ireland $0.066B 21.07
CAS Medical Systems (CASM) United States $0.053B 0.00
Neurotrope (NTRP) United States $0.048B 0.00
ImmuCell (ICCC) United States $0.043B 0.00
Capricor Therapeutics (CAPR) United States $0.029B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.018B 0.00
Senestech (SNES) United States $0.017B 0.00
Akers Biosciences Inc (AKER) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00